Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Assets (2016 - 2025)

Historic Assets for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $1.6 billion.

  • Collegium Pharmaceutical's Assets fell 170.17% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 170.17%. This contributed to the annual value of $1.7 billion for FY2024, which is 4550.68% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Assets stood at $1.6 billion for Q3 2025, which was down 170.17% from $1.6 billion recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Assets registered a high of $1.7 billion during Q4 2024, and its lowest value of $646.1 million during Q1 2021.
  • Its 5-year average for Assets is $1.2 billion, with a median of $1.2 billion in 2022.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Assets skyrocketed by 9288.17% in 2022, and later tumbled by 1322.37% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Assets (Quarter) stood at $692.1 million in 2021, then skyrocketed by 69.65% to $1.2 billion in 2022, then fell by 2.63% to $1.1 billion in 2023, then soared by 45.51% to $1.7 billion in 2024, then dropped by 3.38% to $1.6 billion in 2025.
  • Its Assets was $1.6 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.6 billion in Q1 2025.